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KAJIAN KE ATAS SIFAT-SIFAT ANTIKULAT DAN  
ANTIKANSER LATEKS B-SERUM DAN SUB-FRAKSI  
Hevea brasiliensis 
 
 
ABSTRAK 
 
 
Kajian terdahulu menggunakan lateks B-serum yang diekstrak daripada 
Hevea brasiliensis untuk menguji sifat antikanser pada sel-sel HeLa telah merintis 
jalan untuk menjalankan analisis lanjutan dengan menggunakan pelbagai jenis 
kumpulan sel-sel kanser manusia dengan indeks terapeutik yang lebih tinggi. Dalam 
kajian ini, toksisiti lateks B-serum (WB) dan sub-fraksinya (DBP, DBS, BBP dan 
BBS) telah dinilai dengan Ujian Maut Udang Air Masin (BSLT). Ciri-ciri antikanser 
dinilai dengan  menggunakan ujikaji MTT di mana panel sel-sel kanser yang berasal 
dari manusia telah digunakan. Ciri-ciri antikulat Hevea brasiliensis latex B-serum 
kemudian diuji menggunakan kaedah peresapan cakera , kepekatan perencatan 
minimum (MIC) dan kepekatan antikulat minimum (MFC). Mekanisme kematian sel 
yang berkemungkinan diinduksi oleh WB dan sub-fraksinya telah dikaji dengan 
menggunakan kaedah fragmentasi DNA, diikuti oleh kaedah "real-time reverse 
transcriptase- qualitative polymerase chain reaction" (RT-qPCR).  Keputusan 
daripada BSLT menunjukkan bahawa WB dan sub-fraksinya  mempunyai tahap 
ketoksikan yang rendah ( 461.0 mg/ml ) menurut klasifikasi daripada Meyer et al., ( 
1982). Keputusan ini turut disokongkan oleh ujikaji MTT bahawa keupayaan sel 
Hs27 (bukan berasal daripada kanser) tidak terpengaruh oleh rawatan WB dan sub-
fraksi di mana keupayaan sel itu dikekalkan melebihi  90% walaupun selepas 72 jam 
rawatan. Sementara itu, di kalangan keenam-enam barisan sel kanser manusia, hanya 
barisan HepG2 dan MDA-MB231 menunjukkan kencenderungan yang tinggi ke arah 
rawatan WB dengan nilai LC50 masing-masing pada 8.657 µg/ml dan 85.86 µg/ml, 
 xx 
dan rawatan DBP dengan nilai LC50 pada 1.172 µg/ml and 5.364 µg/ml masing-
masing. Walaubagaimanapun, ujikaji yang dijalankan dengan menggunakan sub-
fraksi BBS dan BBP tidak memaparkan keputusan yang sama. Menariknya, MCF-7 
yang merupakan satu lagi barisan sel kanser payudara manusia tidak menunjukkan 
sebarang kecenderungan seperti yang ditunjuk oleh MDA-MB231. Ini telah 
mencadangkan bahawa lintasan kematian sel apoptosis yang bersandar kaspase-3 
berkemungkinan teraruh semasa rawatan. Dalam kaedah fragmentasi DNA, tiada 
penanggan DNA dapat diperhatikan  dan keputusan RT-qPCR yang dijalankan 
menunjukkan ekspresi yang rendah oleh gen bax dan kaspase-3 setelah rawatan 
dengan WB dan DBP. Keputusan ini menunjukkan tiada lintasan apoptosis dapat 
diaruh pada kedua-dua barisan sel HepG2 dan MDA-MB231 yang rentan pada sub-
fraksi WB dan DBP. Dalam ujian keterentanan antikulat, WB menunjukkan zon 
perencatan terhadap Candida albicans manakala tiada zon perencatan yang diperhati 
terhadap Aspergillus niger. Nilai MIC yang diperolehi daripada C.albicans yang 
dirawat dengan WB ialah 2.5 mg/ml. Sabagai kesimpulan, kesemua keputusan yang 
diperolehi menyarankan bahawa sub-fraksi DBP, harus diambilkira untuk kajian 
lanjutan supaya sifat antikanser yang berpotensi dapat diterokai memandangkan ia 
dapat meminimakan jangkitan yang disebabkan oleh C. albicans, sejenis agen 
jangkitan oportunis dalam pesakit-pesakit kompromi-imun. Sebagai tambahan, 
mekanisme untuk menentukan lintasan kematian sel yang mana diaruh setelah 
dirawat dengan B-serum juga memerlukan penjelasan. 
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 STUDIES OF THE ANTIFUNGAL AND ANTICANCER 
PROPERTIES OF Hevea brasiliensis LATEX B-SERUM  
AND THEIR SUB-FRACTIONS  
 
 
ABSTRACT 
 
 
Previous studies using latex B-serum, extracted from the Hevea brasiliensis 
latex has exhibited its anticancer properties on HeLa cells. This has paved the way 
further analysis of the anticancer properties on different human cancer cell lines with 
higher therapeutic index. In this study, toxicity of latex whole B-serum (WB) and its 
sub-fractions (DBP, DBS, BBP and BBS) was first assessed using brine shrimp 
lethality test (BSLT). Anticancer properties were assessed using MTT assay where a 
panel of human cancer-origin cells was applied.  Antifungal properties of Hevea 
brasiliensis latex B-serum was then tested using disc diffusion, minimum inhibitory 
concentration (MIC) and minimum fungicidal concentration (MFC) assay. Possible 
cell death mechanism induced by WB and its sub-fractions was studied using DNA 
fragmentation assay, followed by real-time reverse transcriptase- quantitative 
polymerase chain reaction (RT-qPCR). Results from BSLT indicated that WB and its 
sub-fractions have low toxicity level (461.0 mg/ml) according to the classification by 
Meyer et al., (1982). This result was further confirmed by MTT assay that the Hs27 
(non-cancer origin) cell viability was not affected by the treatment of WB and its 
sub-fractions where the cell viability was remained above 90% at treatment up to 72 
hours. Meanwhile, among the six human cancer-origin cell lines tested, HepG2 and 
MDA-MB231 cell lines showed high susceptibility towards the treatment of WB 
with the LC50 value 8.657 and 85.86 µg/ml, respectively and DBP with the LC50 
value 1.172 and 5.364 µg/ml, respectively. However, no similar effect was observed 
in BBP and BBS sub-fractions treated cells. Interestingly, similar effects were not 
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observed in MCF-7, another tested human breast cancer cell line, suggesting that 
caspase-3 dependent apoptosis cell death pathway might be induced during the 
treatment. In DNA fragmentation assay, no DNA laddering was observed and RT-
qPCR results showed low expression of Bax and caspase-3 genes when the related 
cells were treated with WB and DBP confirming the fact that no apoptosis pathway 
was induced in both HepG2 and MDA-MB231 cell lines that were susceptible to WB 
and DBP sub-fractions. In the disc diffusion antifungal test, WB showed an 
inhibition zone against Candida albicans while this was not observed with 
Aspergillus niger. The MIC value obtained for WB-treated C. albicans was 2.5 
mg/ml. It is highly recommended that DBP sub-fraction should be subjected to 
further studies to explore the potential anticancer properties in view of developing a 
drug with additional ability to minimize infection caused by C. albicans, an 
opportunistic infectious agent in immune-compromised patients. In addition, the 
mechanism(s) of cell death induced by the sub-fraction also needs to be elucidated.  
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CHAPTER 1 
 
1.0 INTRODUCTION 
 
Candidiasis is a common infection of the skin, nails, oral cavity, esophagus and 
vagina and in critically ill non-neutropenic patients (Eggimann et al., 2003), caused 
by the Candida genus accounting for more than 90% of candidiasis cases (Douglas, 
2003; Edward, 1995). Systemic yeast infections are a common consequence of 
immuno-suppression, long-term indwelling catheters, and endocrinopathies. Candida 
albicans is the most common pathogen causing the fungal opportunistic infection. 
Additionally, it has the ability to adhere to host surfaces or to prosthesis leading to 
the formation of biofilms which further facilitate their adhesion, infection and 
resistance to the antifungals (Parahitiyawa et al., 2006). Aspergillus spp is another 
documented causative agents of human disease while Aspergillus niger being the 
first most common causative species (Kwon-Chung & Bennett, 1992). With 
pathogenic fungi, the situation is not so bright, where amphotericin B was for many 
years the only treatment available for fungal infections. Due to its severe toxicity 
level that would lead to impairment of renal function, the use of amphotericin B has 
been limited (Hossain & Ghannoum, 2000) for treatment of human diseases caused 
by fungal infection.  Hence, increasing incidence of drug-resistant pathogens has 
drawn the attention of the pharmaceutical and scientific communities towards studies 
on the potential antimicrobial activity of plant-derived substances, an untapped 
source of antimicrobial chemotypes, which are used on traditional medicine in 
different countries (Savoia, 2012). In recent years, the antifungal drug discovery is 
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accelerated due to various challenges such as limited number of effective anti-fungal 
drugs, toxicity of the available anti-fungal drugs, resistance of fungi to commonly 
use anti-fungal drugs, relapse of fungal infections and the high cost of anti-fungal 
drugs (Mustafa et al., 1999; Klepser, 2001; Khan et al., 2003; Runyoro et al., 2006).   
Compared with chemical synthesis, plant-derived natural products represent 
an attractive source of biologically active agents since they are natural and available 
at affordable price (Ghosh et al., 2008). Medicinal plants represent a rich source of 
antimicrobial and antifungal agents (Mahesh & Sastish, 2008; Ali et al., 2001; Ho et 
al., 2001). However, many plants that were used as the resources of natural products, 
have not much been thoroughly explored so far. Latex serum had been reported to be 
anti-microbial due to the presence of hevein, a chitin binding protein, and a number 
of hydrolytic enzymes (Martin, 1991; Parijs et al., 1991), which contained mainly 
latex B-serum. Nevertheless, it has been suggested that latex B-serum alone was not 
sufficient to cause an inhibition of yeast growth (Giordani et al., 1999). Other reports 
tried to attribute the antifungal property of latex B-serum to the enzymatic activities 
(Jacob et al., 1993). If properly studied, Hevea extract could potentially be employed 
as a relatively low cost resource for various antimicrobial activities due to the 
simplicity of latex preparation and the abundance of latex that can be obtained in 
rubber producing regions. 
Screening by using in-vitro evaluation is a useful tool for the discovery of 
new potential antifungal agents from natural products such as essential oil and 
extracts derived from plants (Veronica et al., 2011). The present study was also 
aimed at examining the antifungal property of latex B-serum based on the difference 
between C. albicans (single-cell fungus) and Aspergillus niger (a filamentous 
fungus). In addition, this antifungal study would serve as a preliminary test in 
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characterizing latex B-serum activities in biological system before embarking on 
mammalian cell-based cytotoxicity assay.  
Toxicity test is as of most basic parameter to be conducted to identify the 
toxicity level of a substance and decipher if it could be further developed into next 
step. Bioactive compounds are almost always toxic in high doses. Pharmacology is 
simply toxicology at a lower dose, and toxicology is simply pharmacology at a 
higher dose. Thus, in vivo lethality in a simple zoologic organism can be used as a 
convenient monitor for screening and fractionation in the discovery and monitoring 
of bioactive natural products (McLaughlin et al., 1991). Brine shrimp lethality test 
(BSLT) is one of the common and easy handled method to study toxicity level of a 
test substance (McLaughlin et al., 1998).  
An integrated part of cancer cell development is the resistance to 
programmed cell death (apoptosis). Re-establishment of apoptosis in cancer cells is a 
target mechanism for anticancer agents (Joshi et al., 1999). In fact, many of the 
cancer research studies have been carried out to study the mechanism of cell death 
induced by natural products. Many conventional anticancer drugs have an associated 
lack of safety by their toxicity. Relatively faster mutations in tumor cells, compared 
to normal cells, pose a significant obstacle in treatment of cancer (Vandana et al., 
2011). In spite of the several successes of previously studied anticancer plant 
products, the development of multi-drug resistance in cancer chemotherapy is still 
one of the major problems (Xu et al., 2009).  
Preliminary studies on latex whole B-serum (WB) has shown the potential in 
anticancer properties (Ong et al., 2009). Further detailed studies on the anticancer 
properties of latex B-serum and it’s sub-fractions were conducted in this present 
study by using a panel of human cancer-origin cell lines from different sites of the 
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body. In line of this, a human non-cancer-origin cell line was employed in the same 
experiment to investigate if the anticancer effects would be detrimental to other non-
cancer-origin cells if it is to be developed into anticancer drugs in the future. It would 
be an advantage if the latex B-serum could be tested on its antifungal effects, 
especially on Candica albicans which is an opportunistic fungus that caused 
infection in immune-compromised cancer patients. As of to date, there was no work 
being carried out to investigate on the toxicity level of the latex B-serum. Therefore 
in this thesis, further experiments were undertaken to explore the toxicity level, 
antifungal properties onto Candida albicans, and to identify the specificity of the 
latex B-serum towards human cancer-origin cell lines using appropriate and reliable 
bioassays.  
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1.1 OBJECTIVES 
 
The objectives of the work carried out in this thesis are as follows: 
 To determine the level of toxicity of latex whole B-serum (WB) 
 To investigate the antifungal properties of latex whole B-serum (WB) 
 To investigate the anticancer properties of latex whole B-serum (WB) and its 
sub-fractions through cell-based assays on various human cancer-origin and non-
cancer-origin cell lines. 
 To develop the median lethal concentration (LC50) values of the latex whole B-
serum and its sub-fractions in anticancer studies using probit analysis method.   
 To determine the anticancer activities of latex whole B-serum (WB) and its sub-
fraction (Dialyzed B-serum Precipitate - DBP) in inducing apoptosis of cancer 
cells through DNA fragmentation assay and real time reverse transcriptase - 
quantitative polymerase chain reaction (RT-qPCR).  
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CHAPTER 2 
 
2.0 LITERATURE REVIEW 
2.0.1 Current trends of cancer  
Since 1990 there has been a 22% increase in cancer incidence and mortality with the 
four most frequent cancers being lung, breast, colorectal, and stomach cancers and 
the four most deadly cancers being lung, stomach, liver, and colorectal cancers 
(Parkin et al., 2001). Over ten million new cases of cancer (all sites excluding non-
melanoma skin), with over six million deaths, were estimated in the year 2000 
(Parkin, 2001; Parkin et al., 2001). Cancer is the second leading cause of death in the 
United States (U.S.), surpassed only by cardiovascular disease as reported by Jemal 
et al., (2005). Breast cancer appeared to be the most frequent cancer, all residence in 
Malaysia, according to the National Cancer Registry Report year 2007 and Globocan 
(2008). While the most common cancer occurred among women  in Malaysia  is 
breast cancer which  is 26.5 percent,  it  is  the highest number of statistics compared  
to another cancer such as cervix uterine, 12.6 percent, Colorectal 9.9 percent, lung, 
5.8 percent and ovary 5.4 percent (Globocan, 2008).  Experts project that by the year 
of 2010 about 1.35 million new cases of the disease will be diagnosed per year. The 
proportion of these people who will die from breast cancer is unknown (Shadiya et 
al., 2012). Nonetheless, in US, an estimation of 230,480 new cases of invasive breast 
cancer will be diagnosed among women in the year of 2011 based on 1995-2007 
incidence rates in US, by the American Cancer Society. However approximately 
39,520 women are expected to die from breast cancer. Only lung cancer accounts for 
more cancer deaths in women (Rick et al., 2011). Lung cancer being the most 
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common cancer covering 16.5% of all new cases in men while breast cancer being 
the most common cancer diagnosed in women as high as 23% of all new cases in 
women  (IARC, 2012).  
This could be possibly being a result of world cancer westernization trends. 
Less developed countries have been becoming more “westernized” due to rapid 
increase changes in terms of social and economy. As such, many of those infection-
related cancers such as cervix and stomach cancer cases have been reduced, 
alongside increasing incidence rates of cancers more associated with reproductive, 
dietary and hormonal factors such as female breast, prostate and colorectal cancers 
(IARC, 2012).  
Viewing at the current trends in major cancers globally, it is projected in the 
future that there will be increasing to 22 million new cases each year by 2030, 
representing a 75% increment compared with 2008 (IARC, 2012).  In line with this, 
more efforts to develop effective cancer controls as well as cancer treatments are 
highly required with this knowledge about cancer burden as reported.  
 
2.0.1(a) Plant-based anticancer agents 
Traditionally, it is believed that plant-based drugs have fewer side effects when 
consumed, unlike those synthetically produced in laboratory. There were at least 120 
distinct chemical substances derived from plants used to treat various sicknesses, and 
to name a few such as anti-inflammatory, pain killer, analgesic, laxative, local 
anaesthetic, antitumor  agent, etc. (Leslie, 2000).  
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In particular, researches involved in searching anticancer agents from plant 
sources began in earliest in the 1950s. Various anticancer agents were discovered and 
developed such as vinca alkaloids, vinblastine and vincristine, and the isolation of 
the cytotoxic podophyllotoxins (Cragg & Newman, 2005). Among all, vinca 
alkaloids, vinblastine and vincristine were the first agents that advanced into clinical 
use for the treatment of cancer (Cragg & Newman, 2005). Combination of 
vinblastine, vincristine and other chemotherapeutic drugs are able to treat cancers 
such as leukemias, lymphomas, advanced testicular cancer, breast and lung cancers, 
and Kaposi’s sarcoma effectively (Cragg & Newman, 2005). Paclitaxel, extracted 
from the bark of Pacific Yew trees, was clinically introduced to the US market in the 
early 1990s (Wani et al., 1971; Rowinsky et al., 1992) due to its activity against 
human ovarian cancer, advanced breast cancer, small and non-small cell lung cancer 
(Rowinsky et al., 1992). The natural alkaloid camptothecin isolated from the Chinese 
tree Camptotheca acuminate is another useful chemotherapeutic agents used in 
treatment of gastric, rectal, colon and bladder cancers (Cragg & Newman, 1999; 
Wall et al., 1966).  
Above mentioned were among the first few anticancer drugs that were 
discovered from plants and developed into useful chemotherapeutic drugs. This has 
evidenced that plant-based anticancer drugs is no more a new era. Despite existing 
anticancer drugs found in the market, demand in searching for potential anticancer 
drug, with equivalent or higher therapeutic index with little side effects, is getting 
higher. In addition, various factors that lead to anticancer drugs resistance have 
prompted scientists to continue searching for more effective anticancer drugs. 
Eventually, increasing amount of cancer research is being directed towards the 
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investigation of plant-derived anticancer compounds, many of which have been used 
in traditional herbal treatments for centuries.    
 
2.1 Introduction to Hevea brasiliensis  
2.1.1 Hevea brasiliensis and its origin 
Rubber is a well-known tropical tree crop that mainly grown for industrial 
production of latex, natural rubber (NR). It is scientifically known as Hevea 
brasiliensis (Mueller (Arg.). Latex is obtained by tapping the rubber tree bark and 
excreted from the latex vessels (Figure 1.0). Production of good quality of latex 
required stable rainfall and high temperature throughout the year. Richness of soil is 
less important in comparison to its well drainage.   
The genus Hevea is native to South America, where it grows wild in the 
Amazon and Orinoco valleys. Before the discovery of the New World, native Indians 
used the latex of various plants for making balls, bottles, crude footwear and 
waterproofing fabric. Only one of these plants, Hevea brasiliensis later developed as 
the major latex-producing crop. The first rubber plantations in Malaysia were 
established as early as 1890. Hevea was introduced in Africa early in the 20th 
century: in Uganda and Nigeria (1903), Congo (1904), and Liberia (1924) by the 
Firestone Tyre and Rubber Company. Today, most latex production is concentrated 
in industrial estates in tropical Africa and the Far East (Verheye, 2010).  
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Figure 1.0: Cross section of an adult tree showing the composition of the bark and 
the position of the latex vessels in the soft bark tissue (Courtesy Boedt, 2001). 
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2. 1. 2 Hevea brasiliensis latex and its composition 
Natural rubber exists as latex, a milky white sap, which is colloidal suspension of 
rubber particles in liquid form. The latex is extracted from the rubber tree and 
collected for processing into a either dry rubber or latex concentrate. The economic 
life of latex-yielding tress ranges from 20 to 30 years. 
Natural latex of Hevea brasiliensis is the cytoplasm of specialized cells 
known as laticifers. Upon high speed centrifugation (Figure 1.1), latex is separated 
into the rubber cream, the latex serum (C-serum) and the 'bottom fraction' which 
consists mainly of vacuole-like organelles called lutoids. The lutoids contain a fluid, 
B-serum, which has long been of interest to biochemists and physiologists as it 
contains several hydrolases and some pathogenesis-related proteins. B-serum was 
obtained by repeatedly freeze-thaw of the ‘bottom fraction’ followed by high speed 
centrifugation. Based on the research done by Jacob et al. (1993), it has been shown 
that there were many low molecular weight organic, mineral solutes as well as large 
quantities of anionic and cationic proteins which could exert chitinase and/or 
lysozyme enzymatic properties in lutoids.      
 
               
    Figure 1.1 
 
The separated zones of Hevea brasiliensis natural 
latex can be observed after centrifugation. The 
various zones are distinguishable by colours or 
texture or both. (White rubber layer, clear solution 
and yellowish pellet). Clear solution is the latex B-
serum solution.  
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                    The bottom fraction of fresh latex consists of many organic non-rubber 
constituents such as proteins, phospholipids, ubiquinol, sterols, trigonelline and 
ergothioneine (Archer et al., 1969).  
The proteins of H. brasiliensis latex were being studied by Archer et al. 
(1955). Several experiments were conducted such as elementary analyses, protein 
nitrogen analyses and paper electrophoresis, in order to understand the protein 
contents in natural rubber latex (Archer et al., 1955).  
Following that, the chemistry of lutoid was also being studied by other 
researchers. Each composition of lutoids and their functions are summarized in Table 
1.1. 
 
Table 1.1: Lutoid compositions in latex B-serum and its function. (Source: Jacob 
et al., 1993) 
 
Structure Constituents Functions 
Membrane Phosphatidyic acid 
ATPase 
Pyrophosphatase 
NADH-cytochrome c-reductase 
Influx proton pump 
Outgoing pump of protons 
Outgoing pump of protons 
Vacuoles 
Contents 
(pH 5.5) 
Anionic proteins (hevein) 
Cationic proteins (heveamines A & B) 
Hydrolases acids (acid phosphatase, 
mannosidase, RNase, DNase, etc.) 
Peroxidase 
Strong antifungal activities; 
allergens 
Chitinase activities (Martin, 
1991.) 
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Latex B-serum extracted from H. brasiliensis rubber tree has long ago been 
well researched for its antifungal properties and vase industries for rubber products. 
In recent year, researches involved using this latex B-serum and its sub-fractions to 
treat human cancers were initiated by Rubber Research Institute Malaysia (RRIM) 
though it is still in infant stage.  
 
2. 1. 3 Pharmacological activities of Hevea brasiliensis latex 
Malaysia is a country that hosts thousands of endemic plants and animals with 
limitless potential for natural products discovery and development. It is often said 
that the myriad species found in tropical rain forests may harbour cures to many 
diseases such as cancer, diabetes, hypertension and so on, that afflict the world, and 
that the development of drugs based on these species could help pay for the forests’ 
conservation. Whilst being the world third largest rubber producers for natural rubber 
in the world, the potential use of natural rubber and its properties shall be exploited 
for more industries and not only limited to rubber industry.  
Since 1991, it was founded that hevein, as a small cysteine-rich protein in the 
latex of H. brasiliensis, displayed antifungal properties against eight fungi tested 
(Botrytis cinerea, Fusarium culmorum, Fusarium oxysporum f. sp. pisi, Phycomyces 
blakesleeanus, Pyrenophora triticirepentis, Pyriculariaoryzae, Septoria nodorum, 
and Trichoderma hamatum) (Parijs et al., 1991). It was suggested in the same study 
that the antifungal properties of the hevein might be due to the chitin-binding 
properties of hevein.   
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Later in the year of 1999, it was reported that both lutoidic and cytoplasmic 
(L-serum and C-serum, respectively) did not show yeast cell growth inhibition 
(Giordani et al., 1999). However, determination of glycosidic activities in latex L-
serum from H. brasiliensis showed strong activity of N-acetyl-β-D-glucosaminidase 
and, in a lesser level, α-D-mannosidase activity, two enzymatic activities which are 
potentially able to degrade the cell wall of Candida albicans (Giordani et al., 1999). 
Also, in the same article, it was reported that synergy occurs when the antifungal 
effect resulting from a combination of low concentration of latex serum and 
fluconazole is greater than the sum of separate activities of each member of that 
combination (Giordani et al., 1999). Subsequently, it was also evidenced that there is 
a synergistic effect between H. brasiliensis latex serum and amphotericin B against C. 
albicans (Giordani et al., 2002). As the technology advanced, a much simpler 
method to obtain a pure hevein sample from H. brasiliensis was developed by 
Kanokwiroon et al., (2008). The results showed a strong inhibitory effect of that pure 
hevein sample against Candida spp (Kanokwiroon et al., 2008). It was predicted that 
proteins of not larger than 15-20 kDa will pass through the fungal cell wall, while 
hevein with a molecular size of 4.7 kDa could penetrate the fungal cell wall matrix 
and exhibited the antifungal property (Kanokwiroon et al., 2008).  
 Recently, preliminary experiments carried out using the rubber extract from 
H.  brasiliensis sub-fractions on various cancer-origin and non-cancer-origin cell 
lines have shown that specific sub-fraction (Latex B-serum with higher molecular 
weight proteins – BHM) exerted interesting anticancer properties (Ong et al., 2009). 
The sub-fractions were able to specifically reduce high number of cancer-origin cells, 
Hela cells as used in this particular study, with a therapeutic index equivalent or 
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higher than the existing anticancer drugs found in the market. Meanwhile no anti-
proliferation effects were observed in treated non-cancer-origin cells.  
2. 1. 4 Traditional uses of Hevea brasiliensis latex 
The primary product of rubber in the manufacture of a variety of rubber 
products are for the automotive,  mining, agriculture, shipping, chemicals, 
pharmaceutical, and consumer industries. A secondary product is lumber. Other 
rubber products is manufactured for medical and consumers uses are inflatable, 
footwear, sporting goods, toys, bicycles and motorcycles tires, and latex products 
such as globes, prophylactics, medical tubings, and feeding bottle nipples.  
 
2.2 Toxicity Evaluation 
 
Toxicity, also known as the adverse effects can be tested using various biological 
assays. The development of methods of biological assay which estimate the potency 
of solutions from observations of their effects on living tissues is one of the 
fundamental achievements of pharmacology. During the past decade, traditional 
systems of medicine have become increasingly important in view of their safety. 
Current estimates suggest that, in many developing countries, a large proportion of 
the population relies heavily on traditional practitioners and medicinal plants to meet 
primary health care needs (Krishnaraju et al., 2006).  Knowledge of the potential 
toxicity on new synthetic chemicals was absent prior to exposures of the general 
public has caused a in the mid-twentieth century (Bhardwaj & Gupta, 2012). Hence, 
the toxicity remains the first issue to be solved before any further steps taken for 
anticancer drug development for human consumption.  
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2.2.1 Acute, sub-acute and chronic toxicity test 
These types of toxicity test usually involved at least a rodent and a non-rodent animal 
for potential toxicity evaluation due to the different responses of the species towards 
a toxic agent.  
Acute toxicity test was generally the first test conducted with single or a brief 
exposure, either by route of oral, dermal or inhalation exposure. Young adults of rats 
or rabbits are in preference to be the basic parameters for acute toxicity tests. It is 
often used to determine the therapeutic index, i.e. ratio between the lethal dose and 
the pharmacologically effective dose in the same strain and species (LD50/ ED50). 
The greater the index, the safer is the compound (Bhardwaj & Gupta, 2012).  
In chronic toxicity test, repeated-dosing toxicity studies are essential to 
determine the side effect/ toxicity from the exposure for a drug at lower dosage than 
those used in acute toxicity studies. It also determines safe dosages to be used in the 
initial human clinical trials. The duration for chronic toxicity test is set from 1 to 2 
weeks to 1 to 2 years; depended mainly upon the requirement of treatment and the 
118 Animals in Drug Development intended clinical dosing regimen. Chronic 
toxicity test is encouraged to be conducted in stages so that the results of one study 
can be used to design the subsequent study of a longer duration. For instance, the 
first stage is set at 2 weeks, followed by 1-month, 3-month, 6-month and then 1-year 
studies. In selecting the animals for chronic toxicity test, young adults of at least two 
species, rodent and non-rodent as in rat and dog are the basic parameters.  The 
number of test animals should also be considered for their gender of each species 
(Bhardwaj & Gupta, 2012).  
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Sub-acute toxicity test lies in between acute and chronic toxicity test where it 
is employed to determine toxicity which is likely to arise from repeated exposures of 
several weeks to several months. Various standardized tests for sub-acute test that are 
available such as oral, dermal and inhalation exposure have been developed. 
Depending on the exposure route to be tested, rodents such as rats and rabbits, while 
non-rodent such as dogs will be used as the basic parameter for short term 
assessment (Bhardwaj & Gupta, 2012). 
 
2.2.2 Brine Shrimp Lethality Test (BSLT) 
Considering the animal welfare issues, cost and time consumption issues, brine 
shrimp lethality test (BSLT) is another option used for natural products extracts, 
fractions or pure compounds toxicity test. It is indeed easily mastered, costs effective, 
and utilizes a small amount of test materials (Pisuthanan et al., 2004) compared to 
previously described methods. For instance, the brine shrimp lethality test has 
advantages of being rapid (24 hours), inexpensive (readily available at pet shop in 
dry from), and simple (e.g. no aseptic techniques are required). It easily utilizes a 
large number of organisms for statistical validation using Probit Analysis, and 
requires no special equipment and a relatively small amount of sample (2 – 20 mg or 
less). In addition, it does not require animal serum as is needed for cytotoxicities 
(McLaughlin et al., 1998).  It has been suggested that, animal models would not give 
more information than in vitro screening using a large panel of human tumour cell 
lines. Hence, major efforts were dedicated to the development of in vitro assay based 
on a large panel of human cell lines representing various tumour types (Teicher, 
1997). It was reported that in vivo lethality test has been successively employed for 
bioassay-guided fractionation of active cytotoxic and antitumor agents such as 
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trilobacin from the bark of Asimina triloba (Zhao et el., 1992), cis-annonacin from 
Annona muricata (Rieser et al., 1996) and ent-kaur-16-en-19-oic acid from 
Elaeoselinum  foetidum  (Mongelli et al., 2002). According to the classification by 
Meyer et al. (1982), crude extracts and pure substances are classified as toxic when 
LC50 value <1000 µg/ml or non-toxic when LC50 >1000 µg/ml. 
 
 2.3 Anticancer properties 
2.3.1 In-vitro cytotoxicity assay  
The evaluation of compounds from plant extract, such as cytotoxic agents, 
necessitates screening of a great number of chemicals. Animal models have always 
played an important role in drug evaluation, but with the development of a large 
number of cytotoxic drugs, animal models are too costly and the delay is too long for 
the models to be used for high-throughput screening. Furthermore, experiments 
involving animals are often facing more hindrance due to ethical issues; cell-based 
assay is therefore a good approach to gather enough experimental data before 
moving to animal models.  
Cell-based toxicity test is also known as in-vitro cytotoxicity test. In vitro 
(literally 'in glass') testing methods are employed primarily to identify potentially 
hazardous chemicals and/or to confirm the lack of certain toxic properties in the early 
stages of the development of potentially useful new substances such as therapeutic 
drugs, agricultural chemicals and food additives. Most toxicologists believe that in 
vitro toxicity testing methods can be more useful, more time effective and cost 
effective than toxicological studies in living animals (which are termed in vivo or "in 
life" methods).  
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There are various types of endpoint assay can be conducted for cytotoxicity 
evaluation.  Several endpoint assays are briefly discuss in the following:  
Cell viability endpoint assay using (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide) salt or MTT, is one of the simple, accurate and yields 
reproducible results, yet common and reliable cell-based cytotoxicity endpoint assay. 
This method measures on the mitochondrial activity of the live and viable cells after 
treatment. Mitochondrial dehydrogenases of viable cells cleave the tetrazolium ring, 
leading to the formation of purple crystals which are insoluble in aqueous solutions. 
The crystals are re-dissolved in acidified isopropanol and the resulting purple 
solution is measured spectrophotometrically. An increase or decrease in cell number 
results in a concomitant change in the amount of formazan formed, indicating the 
degree of cytotoxicity caused by the test material. The more is the amount of formed 
formazan, the safer is the substance. This treatment destroys the cells under 
investigation allowing only a single time point measurement and it is generally 
cytotoxic (Mossman, 1983). Currently there is an updated version of the validated 
MTT method, called MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2 tetrazolium) assay has the advantage of 
being soluble and hence no solubilisation step is required. MTT assay is employed in 
this study.  
Another cell viability endpoint can be Neutral Red uptake. Neutral Red (NR), 
a weak cationic dye penetrates cellular membranes by non-diffusion and accumulates 
intercelluarly in lysosomes. Viable cells take up the NR dye, damaged or dead cells 
do not. In fact, Neutral red (3-amino-m-dimethylamino-2-methyl- phenazine 
hydrochloride) has been used previously for the identiﬁcation of vital cells in 
cultures. This assay quantiﬁes the number of viable, uninjured cells after their 
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exposure to toxicants; it is based on the uptake and subsequent lysosomal 
accumulation of the supravital dye, neutral red. Quantiﬁcation of the dye extracted 
from the cells has been shown to be linear with cell numbers, both by direct cell 
counts and by protein determinations of cell populations (Borenfreund & Puerner, 
1985, 1986). 
Besides measuring the cell viability after exposure to the toxicants, there are 
also assay that measured on the cell death. For instance, one parameter for cell death 
is the integrity of the cell membrane, which can be measured by the cytoplasmic 
enzyme activity released by damaged cells. Lactate dehydrogenase (LDH) is a stable 
cytoplasmic enzyme present in all cells. It is rapidly released into the cell culture 
supernatant upon damage of the plasma membrane (Korzeniewski & Callewaert, 
1983). The LDH activity is determined in an enzymatic test. The ﬁrst step is the 
reduction of NAD+ to NADH/H+ by the LDH-catalyzed conversion of lactate to 
pyruvate. Following of that, the catalyst (diaphorase) transfers H/H+ from 
NADH/H+ to the tetrazolium salt 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-
phenyltetrazoliumchloride (INT), which is reduced to a red formazan (Decker and 
Lohmann-Matthes, 1988; Lappalainen et al., 1994; Nachlas et al., 1960). The greater 
the red formazan formed, more toxic is the substance.  
Another possible endpoint assay is measured on the total protein content of 
the treated cells. This Sulforhodamine B (SRB)  assay  is  based  on  binding  of  the  
dye  to basic  amino  acids  of  cellular  proteins,  and  colorimetric  evaluation  
provides  an  estimate  of  total  protein mass, which  is  related  to  cell  number.  
This assay  has been widely  used  for  the  in vitro measurement  of cellular protein  
content  of both  adherent  and  suspension cultures.  The Sulforhodamine B method, 
is simple, accurate and yields reproducible results. The cells are briefly washed, fixed, 
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and stained with the dye. The incorporated dye is then liberated from the cells with a 
Tris base solution. An increase or decrease in the number of cells (total biomass) 
results in a concomitant change in the amount of dye incorporated by the cells in the 
culture. This indicates the degree of cytotoxicity caused by the test material. The 
advantages of this  test  as  compared  to other  tests  include better  linearity, higher  
sensitivity,  a stable  endpoint  that  does  not  require  time-sensitive measurement, 
and  lower cost. The disadvantage lies in the need for the addition of trichloroacetic 
acid (TCA) for cell fixation. This step is critical because, if not  added  gently, TCA 
could dislodge  cells  before  they  become  fixed,  generating possible  artifacts  that 
will  affect  the  results (Giuseppe et al., 2006). 
Cell lines in culture, which are commonly used in many in vitro studies, are 
usually in vitro derived from tumours and are thus transformed. Human cells derived 
from normal tissues need to be immortalized. In other in vitro approaches primary 
cells are used. These cells can only be kept in culture for a certain time (hours to 
days) and in many cases will lose their diﬀerentiated properties during this culture 
time. These intrinsic weaknesses result from the fact that, in vivo, the cells are 
isolated from their natural environment and are no longer integrated into an ordered 
tissue and organ topology. This entails intrinsic limitations concerning reduced 
survival, imbalance of metabolic competence, and lack of cell to cell interaction, 
destroyed organ topology and absence of tissue communication. Furthermore, the 
balance of metabolic activation and inactivation requires a highly ordered interplay 
of many enzymes and cofactors in most cases (Eisenbrand et al., 2002). 
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2.4 In vitro Antifungal Susceptibility Testing (AST) 
Plants have their intrinsic ability to resist pathogenic microorganisms and this has led 
the researchers to investigate their mechanisms of action and isolation of active 
compounds. In view of the large number of the plant species, potentially available for 
the study, it is essential to have efficient systems of the methods to evaluate efficacy 
of medicinal plants as antimicrobial agent.  The evaluation for antimicrobial agent of 
plant origin begins with thorough biological evaluation of plant extracts to ensure 
efficacy and safety followed by identification of active principles, dosage 
formulations, efficacy and pharmaco-kinetic profile of the new drug. This novel 
search entails extensive research and it is therefore imperative to follow standard 
methods to authenticate claims of antimicrobial action (Das et al., 2009). There are 
three main methods to test on antifungal susceptibility, i. e. diffusion, dilution and 
bioautography (Cos et al., 2006).  
 
2.4.1 Agar disc diffusion method 
Agar disc diffusion method of antimicrobial test was first developed in 1940 
(Heatley, 1944), as a modification of that described by Bauer, Kirby, Sherris and 
Truck (commonly known as Kirby-Bauer test) (Bauer et al., 1959, 1966). It was 
accepted by NCCLS (which now named as Clinical and Laboratory Standard 
Institute, CLSI) and has been widely used nowadays to assay plant extract for 
antimicrobial activity (Freixa et al., 1996; Salie et al., 1996; Ergene et al., 2006).  
The disc diffusion method allows for the simultaneous testing of a large 
number of antimicrobials in a relatively easy and flexible manner. There are three 
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categories of antimicrobial level to be assigned based on the result of the diameter of 
the inhibition zone and the Clinical and Laboratory Standard Institute (CLSI) 
interpretative criteria, namely susceptible, intermediate, or resistant.  Of course, the 
bigger the diameter of the inhibition zone, the more susceptible is the microorganism 
to the antimicrobial.  However, one of the major disadvantages of this method is 
unable to generate a quantitative value such Minimum Inhibitory Concentration 
(MIC) value and it is difficult to examine the susceptibility of fastidious and slow-
growing bacteria (Wilkins & Thiel, 1973; Dickert et al., 1981).  Furthermore, 
different from antimicrobial agents used in clinical settings, there are  currently  no 
standard CLSI  interpretive criteria of disc diffusion results to support natural 
antimicrobials  susceptibility testing; thus, it is unable to explain the zone diameter 
generated by disc diffusion for natural antimicrobials. Besides, disc diffusion is 
labor-intensive and time-consuming (Klancnik et al., 2010).  
It has been reported (Klancnik et al., 2010) that this method is not always 
reliable for determining the antimicrobial activity of natural antimicrobials, i.e., plant 
extract, because the polarity of the natural compounds can affect the diffusion of 
compounds onto the culture medium.  Compounds with less polarity diffused slower 
than more polar ones (Moreno et al., 2006).  Due to these concerns, disc diffusion 
may not be a suitable one to determine the antimicrobial activity of natural 
compounds.   
 
2.4.2 Dilution methods 
Broth dilution method has been categorized into macrodilution and microdilution 
methods. Both the dilution methods have been widely used for many years to 
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accurately measure antibacterial and antifungal activity as well as susceptibility 
testing. It is important to note that the substances normally tested by these methods 
are generally hydrophillic in nature (Janssen et al., 1987).  
The earliest antimicrobial susceptibility testing methods was the 
macrodilution method. This procedure involved preparing two-fold dilutions of 
samples in a liquid growth medium, also called broth, dispensed in test tubes 
(Ericson & Sherris, 1971). After certain period of incubation of the samples with the 
microbes, the tubes were examined for visible bacterial or fungal growth as 
evidenced by turbidity. The lowest concentration of substances that prevented growth 
represented the minimal inhibitory concentration (MIC). The precision of this 
method was considered to be plus or minus 1 two-fold concentration due in large part 
to the practice of manually preparing serial dilutions of the substance. The advantage 
of this technique was the generation of a quantitative result (i.e., the MIC). The 
principal disadvantages of the macrodilution method were tedious, manual task of 
preparing the sample solutions for each test, the possibility of errors in preparation of 
the sample solutions, and the relatively large amount of reagents and space required 
for each test (Jorgensen & Ferraro, 2009). 
The miniaturization and mechanization of the test by use of small, disposable, 
plastic “microdilution” trays has made broth microdilution testing practical and 
popular. It is a widely utilized method, allowing for the simultaneous testing of 
multiple antimicrobials with ease particularly when commercially prepared 
microtiter trays are used. Hundreds of identical trays can also be prepared from a 
single master set of dilutions in a relatively brief period (Jorgensen & Ferraro, 2009). 
Compared with agar-based method, broth microdilution can decrease much labor and 
time. In this study, microdilution method is employed. The advantages of the 
